Global Markets for Telemedicine Technologies
March 09, 2012
Wellesley, Mass. – According to a new technical market research report, GLOBAL MARKETS FOR TELEMEDICINE TECHNOLOGIES (HLC014E) from BCC Research (www.bccresearch.com), the global telehome and telehospital market was valued at $11.6 billion in 2011 and is expected to increase to $27.3 billion in 2016, a five-year compound annual growth rate (CAGR) of 18.6%.
The telehospitals and clinics segment accounted for $8 billion in 2011 and is expected to increase at a CAGR of 16.8% to reach nearly $17.6 billion in 2016.
The telehome segment accounted for $3.5 billion in 2011 and is expected to increase at a CAGR of 22.5% to reach $9.7 billion in 2016.
The telemedicine market can also be segmented into technology (hardware, software, telecom, network) and service segments. The telemedicine technology market is expected to grow from $3.8 billion in 2010 to $4.6 billion in 2011 and $11.3 billion in 2016, with a CAGR of 19.8% over the next five years. The telemedicine service market is expected to grow from $5.9 billion in 2010 to $7 billion in 2011 and nearly $16 billion in 2016, mainly driven by growth in the telehospital service market.
There has been a global focus on the use of telemedicine as a tool to cut down healthcare costs and bring about mammoth savings. Implementation of the new U.S. healthcare law will, if anything, intensify this focus, by increasing the number of people with health insurance and seeking medical services. In the near to mid-term, telemedicine technology offers one of the few ways of enabling healthcare personnel to meet the increased demand without unacceptable delays or other forms of de facto rationing.
This report is intended for telemedicine hardware manufacturers, software providers, telecom and networking companies, the healthcare industry, and healthcare insurance companies. Key takeaways include the identification and quantification of markets for technology and services in the telemedicine market. Opportunities are defined in terms of market forecasts, avenues, trends, market drivers, and competitive gaps.
Global Markets for Telemedicine Technologies( HLC014E )
Publish Date: Mar 2012
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
More in Health Maintenance
- Global Noninvasive Cancer Diagnostics Market to Reach $165.2 Billion by 2030 as Liquid Biopsy, AI-Enabled Screening and Multi-Cancer Detection Tests Transform Oncology
- Long-Term Care and Home Healthcare Technology Market to Reach $64.8 Billion by 2030 as Aging Demographics and Remote Monitoring Reshape Care Delivery
- Thermo Fisher Scientific Inc.: BCC Research Releases Comprehensive 360° Company Analysis
- Healthcare Predictive Analytics Market to Grow at 24.7% CAGR Through 2030
- mHealth Technologies Market Poised for 17.1% CAGR Growth Through 2030
Reports from Health Maintenance
- State of the Life Sciences Industry - 2026 First Quarter Review
- Noninvasive Cancer Diagnostics: Technologies and Global Markets
- Infusion Pumps and Devices: Technologies and Global Markets
- Technologies for Long-Term Care and Home Healthcare: Global Markets
- 3D Protein Structure Analysis: Global Markets
Recent News
- Global Bispecific Antibodies Market to Reach $22.3 Billion by 2030 as Immuno-Oncology Innovation and R&D Investment Accelerate
- Cloud Computing in Cell Biology, Genomics and Drug Development to Reach $15.6 Billion by 2030 as Biological Data Explosion Drives Demand
- Neuroprotective Agents Market to Reach $60.9 Billion by 2030 as Neurological Disease Burden and Aging Populations Drive Pharmaceutical Investment
- Radioligand Therapeutics Market to More Than Double to $4.8 Billion by 2030 as Targeted Cancer Treatments Gain Regulatory Momentum
- Decentralized Clinical Trials Market to Reach $18.8 Billion by 2030 as Digital Health Infrastructure Reshapes Drug Development